Oxytocin
Pitocin · Love Hormone
Oxytocin activates OXTR receptors in both peripheral tissues and the brain. It changes dopaminergic reward signaling and the stress response mediated by the HPA axis. In uterine smooth muscle it stimulates contractions; in the amygdala it influences social recognition. Additional effects involve appetite and gastrointestinal movement.
Not medical advice. Educational reference only.
- Typical dose
- 20–40 IU, not specified, intranasal
- Route
- Intranasal; Intravenous (obstetric use)
- Storage
- Keep refrigerated at 2–8°C and use within 28 days.
What is Oxytocin?
Oxytocin is a naturally occurring hormone with nine amino acids. The hypothalamus makes it, and the posterior pituitary releases it. Its prescription product, Pitocin, has FDA approval for inducing labor and controlling postpartum hemorrhage. Research also examines social attachment, trust, autism spectrum disorder, PTSD, anxiety and metabolic activity. Intranasal delivery is widely investigated for effects in the brain, with access through compounding pharmacies and telehealth; this research route is distinct from the approved obstetric uses.
Mechanism of action
Oxytocin activates OXTR receptors in both peripheral tissues and the brain. It changes dopaminergic reward signaling and the stress response mediated by the HPA axis. In uterine smooth muscle it stimulates contractions; in the amygdala it influences social recognition. Additional effects involve appetite and gastrointestinal movement.
Targets: Oxytocin receptor (OXTR)
Research indications
Hormonal Regulation
Most effectiveEndocrine activity is a principal research focus, with direct effects on hormonal signaling.
Reproductive Health
EffectiveFertility and reproductive medicine are areas of investigation and clinical interest.
Metabolic Support
ModerateHormonal signaling may produce secondary effects on metabolic function.
Research protocols
These are commonly discussed research protocols — not medical advice. Consult a healthcare provider before use.
| Goal | Amount | Frequency | Route |
|---|---|---|---|
| Additional research schedule | 20–40 IU | Not specified | Intranasal |
Interactions
Medications
CautionConsult your prescriber before combining this compound with any medication.
BPC-157
CompatibleNAD+
CompatibleVitamin D
Compatible
How to reconstitute and inject
Diluent: Use bacteriostatic water; avoid saline because it may cause precipitation.
- Let your refrigerated Oxytocin vial warm to room temperature for 15–20 minutes before preparation.
- Disinfect the vial’s rubber closure with an alcohol wipe, then wait until it has dried completely.
- Use a sterile syringe to measure the calculated amount of bacteriostatic water. Avoid saline because precipitation may occur.
- Add the water slowly against the vial’s inner wall. Keep the stream away from the dry powder itself.
- Rotate the vial gently to mix its contents. Do not shake forcefully, because this can damage the peptide.
- Wait 2–3 minutes for the powder to dissolve completely. Check that the liquid is transparent and has no color.
- Measure your calculated subcutaneous dose with an insulin syringe after dissolution.
- Choose the abdomen, upper arm or thigh for injection. Alternate the injection location each time to help prevent lipodystrophy.
- Refrigerate the mixed solution at 2–8°C, and discard any remainder after 28 days. Use these steps only for an appropriate research formulation; follow the specific product instructions for prescription presentations.
What to expect
- Week 1–2
- An early adjustment period may accompany initial effects. Watch for adverse reactions while assessing tolerance.
- Week 2–4
- The main effects may begin to emerge. Change the dose only in accordance with your clinician’s recommendations.
- Week 4–8
- The intended effects may become established during this interval. Review your progress together with your clinician.
- Week 8+
- Reassess the outcome and discuss whether to continue, introduce a cycle break or change the dose. These research expectations do not establish individual treatment outcomes.
Side effects and safety
- Local redness, bruising or mild pain after an injection
- Possible allergic reactions, including rash or hives; stop use if these develop
Oxytocin: approved in the US.
Regulatory status
US
ApprovedFDA — Pitocin is approved by prescription for induction of labor and treatment of bleeding after childbirth. Intranasal psychiatric and behavioral research is distinct from those approved indications.
- Rx required
- Yes
- Telehealth
- Available
Frequently asked questions
Which dosing approaches are discussed?
The starting research approach uses a low dose, followed by titration for the standard approach. Neither approach defines a numeric amount. Frequency depends on the particular protocol, and the route varies; these descriptions therefore do not establish a dosing regimen. Discuss any use with a qualified clinician rather than selecting an amount from these qualitative terms.
What should you know about unwanted effects?
Adverse effects can differ according to dose, administration route and individual response. Begin only at the lowest clinician-directed amount and monitor your response carefully. Seek advice before use, and report any unusual symptoms to your healthcare professional. Human safety is not fully characterized for experimental applications.
How do intranasal and intravenous amounts differ?
Intranasal research uses 20–40 IU, with no frequency specified. Intravenous obstetric dosing varies with the clinical protocol. The IV half-life is approximately 3–5 minutes; central effects after intranasal administration can last roughly 90 minutes. Duration of an effect is distinct from elimination half-life.
References
Intranasal oxytocin in humans: a review of neurobiological and behavioral effects (2013)
Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress. (2003)
Intranasal oxytocin as a treatment for anxiety and autism: From subclinical to clinical applications. (2024)
MacDonald K & MacDonald TM — Oxytocin review (2010) (2010)
PITOCIN (oxytocin) injection — Prescribing Information (2014)